Dr. Kyle Davis Kovacs, MD

Dr. Kovacs practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Kovacs' NPI, 1477971505, was assigned on April 5, 2014. Dr. Kovacs graduated from Albert Einstein College of Medicine in 2014. Dr. Kovacs' New York license number on file is 292978.

Dr. Kovacs' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Kovacs' primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Kovacs to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kovacs practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Kovacs' primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Kovacs is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Kovacs' licenses on file in 2 states: New York and Connecticut.

Dmand AI lists age-related macular degeneration, cataract surgery with lens implant, glaucoma, hypertensive retinopathy, inflammation of iris, laser destruction of retinal or choroid lesions, retinal detachment and retinal occlusion among the conditions Dr. Kovacs treats.

CMS data shows 3,578 Medicare services from Dr. Kovacs across 13 procedure codes in 2024, for 581 Medicare patients. Medicare paid $519,018 for them. Every service was in an office.

CMS counts 581 Medicare patients who saw Dr. Kovacs in 2024. The largest group is 65 to 74, with 248 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kovacs' median patient age at 62, with 54% women.

In 2024, Dr. Kovacs wrote 91 Medicare Part D claims for 36 patients. 48% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $1,088 in total drug cost. In 2023, CMS named 64 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kovacs for performance year 2024, reported through an alternative payment model (APM). Dr. Kovacs accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 53 papers to Dr. Kovacs, published from 2012 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Tomography, Optical Coherence, Retina and Visual Acuity. Dr. Kovacs has published most often in J Vitreoretin Dis. Dr. Kovacs' most frequent co-authors are Donald J. D'Amico, MD, Anton Orlin, MD and Szilard Kiss, MD.

CMS Open Payments shows 17 general payments to Dr. Kovacs from 8 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 66% of the total. Alcon Laboratories Inc paid the most, $1,005.

Dr. Kovacs graduated from Albert Einstein College of Medicine in 2014.

Dr. Kovacs is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.